These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29529076)

  • 41. Correction: The hMLH1 -93G>A Polymorphism and Risk of Ovarian Cancer in the Chinese Population.
    Niu L; Li S; Liang H; Li H
    PLoS One; 2019; 14(5):e0218032. PubMed ID: 31150525
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correction: BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression.
    Nociti V; Santoro M; Quaranta D; Losavio FA; De Fino C; Giordano R; Palomba NP; Rossini PM; Guerini FR; Clerici M; Caputo D; Mirabella M
    PLoS One; 2019; 14(2):e0212906. PubMed ID: 30789956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correction: Correction: AKT Inhibitors Promote Cell Death in Cervical Cancer through Disruption of mTOR Signaling and Glucose Uptake.
    PLOS ONE Staff
    PLoS One; 2016; 11(5):e0155168. PubMed ID: 28886011
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correction: Cancer Mortality in People Treated with Antidepressants before Cancer Diagnosis: a Population Based Cohort Study.
    Sun Y; Vedsted P; Fenger-Grøn M; Wu CS; Bech BH; Olsen J; Benros ME; Vestergaard M
    PLoS One; 2016; 11(5):e0155453. PubMed ID: 27152664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correction: breast cancer screening in Saudi Arabia: free but almost no takers.
    PLOS ONE Staff
    PLoS One; 2015; 10(4):e0124850. PubMed ID: 25853811
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correction: nonequilibrium population dynamics of phenotype conversion of cancer cells.
    PLOS ONE Staff
    PLoS One; 2015; 10(3):e0118133. PubMed ID: 25811756
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correction: galectin-3 as a marker and potential therapeutic target in breast cancer.
    PLOS ONE Staff
    PLoS One; 2015; 10(1):e0116994. PubMed ID: 25621883
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correction: Hormonal contraceptive use and risk of pancreatic cancer-A cohort study among premenopausal women.
    Butt SA; Lidegaard Ø; Skovlund C; Hannaford PC; Iversen L; Fielding S; Mørch LS
    PLoS One; 2019; 14(3):e0214771. PubMed ID: 30921445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correction: The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease.
    Borràs Sans M; Pérez-Fontán M; Martinez-Alonso M; Bajo A; Betriu À; Valdivielso JM; Fernández E;
    PLoS One; 2018; 13(6):e0200226. PubMed ID: 29953560
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correction: MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer.
    Bennani-Baiti B; Dietzel M; Baltzer PA
    PLoS One; 2016; 11(9):e0162936. PubMed ID: 27607428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correction: Epidermal Growth Factor Receptor in Prostate Cancer Derived Exosomes.
    Kharmate G; Hosseini-Beheshti E; Caradec J; Chin MY; Tomlinson Guns ES
    PLoS One; 2016; 11(6):e0157392. PubMed ID: 27295211
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correction: Characterisation of Mesothelioma-Initiating Cells and Their Susceptibility to Anti-Cancer Agents.
    Pasdar EA; Smits M; Stapelberg M; Bajzikova M; Stantic M; Goodwin J; Yan B; Stursa J; Kovarova J; Sachaphibulkij K; Bezawork-Geleta A; Sobol M; Filimonenko A; Tomasetti M; Zobalova R; Hozak P; Dong LF; Neuzil J
    PLoS One; 2016; 11(5):e0156012. PubMed ID: 27186640
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correction: IL-6 Expression Regulates Tumorigenicity and Correlates with Prognosis in Bladder Cancer.
    Chen MF; Lin PY; Wu CF; Chen WC; Wu CT
    PLoS One; 2016; 11(5):e0155774. PubMed ID: 27183128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correction: HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.
    Lee YH; Liu X; Qiu F; O'Connor TR; Yen Y; Ann DK
    PLoS One; 2015; 10(4):e0124853. PubMed ID: 25875848
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correction: Correction: Engineered Promoters for Potent Transient Overexpression.
    PLOS ONE Staff
    PLoS One; 2016; 11(5):e0156345. PubMed ID: 27203078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correction: A Comprehensive Spectroscopic and Computational Investigation to Probe the Interaction of Antineoplastic Drug Nordihydroguaiaretic Acid with Serum Albumins.
    Nusrat S; Siddiqi MK; Zaman M; Zaidi N; Ajmal MR; Alam P; Qadeer A; Abdelhameed AS; Khan RH
    PLoS One; 2016; 11(10):e0164927. PubMed ID: 27736985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correction: the five-to-six-coordination transition of ferric human serum heme-albumin is allosterically-modulated by ibuprofen and warfarin: a combined XAS and MD study.
    PLOS ONE Staff
    PLoS One; 2015; 10(3):e0123144. PubMed ID: 25826303
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correction: Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy.
    Nayak S; Bhatt MLB; Goel MM; Gupta S; Mahdi AA; Mishra A; Mehrotra D
    PLoS One; 2018; 13(8):e0202432. PubMed ID: 30092098
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correction: Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer.
    Di Caro G; Carvello M; Pesce S; Erreni M; Marchesi F; Todoric J; Sacchi M; Montorsi M; Allavena P; Spinelli A
    PLoS One; 2016; 11(5):e0156669. PubMed ID: 27227770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correction: Actin Cytoskeleton Regulation of Epithelial Mesenchymal Transition in Metastatic Cancer Cells.
    Shankar J; Nabi IR
    PLoS One; 2015; 10(7):e0132759. PubMed ID: 26167914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.